Journal List > Pediatr Gastroenterol Hepatol Nutr > v.22(4) > 1129217

TOOLS
Park, Son, Jekarl, Choi, Kim, and Lee: Clinical Significance of Inflammatory Biomarkers in Acute Pediatric Diarrhea
Original Article

Pediatric Gastroenterology, Hepatology & Nutrition 2019; 22(4): 369-376.

Published online: 18 June 2019

DOI: https://doi.org/10.5223/pghn.2019.22.4.369

Clinical Significance of Inflammatory Biomarkers in Acute Pediatric Diarrhea

Yoonseon Park1, Minji Son1, Dong Wook Jekarl2, Hyun Yoo Choi2, Sang Yong Kim1, Seungok Lee2

1Department of Pediatrics, Incheon St. Mary’s Hospital, School of Medicine, The Catholic University of Korea, Incheon, Korea.

2Department of Laboratory Medicine, Incheon St. Mary’s Hospital, School of Medicine, The Catholic University of Korea, Incheon, Korea.

Correspondence to Sang Yong Kim. Department of Pediatrics, Incheon St. Mary's Hospital, School of Medicine, The Catholic University of Korea, 56 Dongsu-ro, Bupyeong-gu, Incheon 21431, Korea. sykim2010@catholic.ac.kr

Correspondence to Seungok Lee. Department of Laboratory Medicine, Incheon St. Mary's Hospital, School of Medicine, The Catholic University of Korea, 56 Dongsu-ro, Bupyeong-gu, Incheon 21431, Korea. lsok@catholic.ac.kr

Received 5 September 2018       Revised 9 October 2018       Accepted 21 October 2018

Copyright © 2019 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition

(open-access):

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Purpose

The aim of this study was to evaluate the clinical significance of inflammatory biomarkers in acute infectious diarrhea among children.

Methods

Clinical parameters including fever, bacterial and viral etiology based on stool culture and multiplex polymerase chain reaction, and nine biomarkers including C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) and leukocytes in blood and calprotectin, lactoferrin, myeloperoxidase, polymorphonuclear elastase, leukocytes, and occult blood in feces were evaluated in children who were hospitalized due to acute diarrhea without underlying disease.

Results

A total of 62 patients were included. Among these patients, 33 had fever, 18 showed bacterial infections, and 40 patients were infected with 43 viruses. Of all the biomarkers, CRP was significantly correlated with fever (p<0.001). CRP, ESR, calprotectin, lactoferrin, myeloperoxidase, fecal leukocytes, and occult blood were significantly associated with infection with bacterial pathogens (p<0.001, p=0.04, p=0.03, p=0.003, p=0.02, p=0.03, p=0.002, respectively). The combination of CRP and fecal lactoferrin at their best cut-off values (13.7 mg/L and 22.8 µg/mL, respectively) yielded a sensitivity of 72.2%, and a specificity of 95.5% for bacterial etiology compared with their individual use.

Conclusion

Blood CRP is a useful diagnostic marker for both fever and bacterial etiology in acute pediatric diarrhea. The combination of CRP and fecal lactoferrin yields better diagnostic capability for bacterial etiology than their use alone for acute diarrhea in children without underlying gastrointestinal disease.

Keywords: C-reactive protein, Biomarkers, Lactoferrin, Child, Diarrhea

INTRODUCTION

Acute diarrhea is a common disease in children. The majority of cases are self-limited, requiring only conservative rehydration. However, acute infectious diarrhea can be clinically serious and is the second leading cause of death in children aged below 5 years, worldwide [12].
The major etiology of acute pediatric diarrhea is viruses. Rotavirus and pathogenic Escherichia coli are important causes of death due to infectious diarrhea [12]. Diarrheagenic bacteria including Clostridium difficile, Salmonella, Shigella, and Campylobacter cause invasive inflammation of the intestine, warranting extensive investigation and appropriate use of antimicrobial treatment [34]. Therefore, accurate and prompt laboratory testing for the differential diagnosis of bacterial versus viral infection in pediatric acute diarrhea may facilitate the prediction of the clinical course and timing of antimicrobial therapy [5].
Serum C-reactive protein (CRP) is an acute-phase reactant, and is utilized for the diagnosis and clinical follow-up of various inflammatory conditions including bacterial infection [67]. Several biomarkers derived from neutrophils in feces correlate strongly with gut inflammatory conditions such as Crohn’s disease or ulcerative colitis. These biomarkers include calprotectin (a calcium- and zinc-binding protein in neutrophils), lactoferrin (an iron-binding glycoprotein present in the secondary granules of neutrophils), myeloperoxidase (MPO), which is released from neutrophil primary granules, and polymorphonuclear elastase (PMN-e) found in neutrophil azurophilic granules [891011]. In particular, fecal calprotectin and lactoferrin are useful biomarkers in distinguishing gut pathogens in children with acute infectious diarrhea without underlying gut disease [481213]. In a previous study, we suggested that fecal lactoferrin was a useful marker for bacterial etiology in adult acute diarrhea, and that multiplex polymerase chain reaction (PCR) facilitated the detection of enteric pathogens [514]. However, limited evidence supports the clinical significance of various fecal biomarkers in acute pediatric gastroenteritis without underlying gut disease.
In this study, we evaluated the clinical significance of noninvasive fecal biomarkers including calprotectin, lactoferrin, PMN-e, and MPO together with blood inflammatory biomarkers including CRP, ESR, and leukocytes in pediatric acute diarrhea.

MATERIALS AND METHODS

This prospective study was approved by the Institutional Review Board of Incheon St. Mary's Hospital (IRB No. OC13TISI0014) in accordance with the ethical standards of the Declaration of Helsinki and written informed consents were obtained before the participants were enrolled. Between June 2013 and July 2014, children were enrolled according to the following criteria: age between 1 month and 18 years, acute diarrheal symptoms within 2 weeks, and admission due to diarrhea-associated moderate-to-severe dehydration, fever (≥38°C) or bloody diarrhea. Children with underlying gastrointestinal diseases including inflammatory bowel diseases, hospital-acquired diarrhea, and other chronic diseases requiring intensive care were excluded.

Inflammatory biomarkers

Blood samples and stool specimens were collected within 24 hours of admission. Blood inflammatory biomarkers including highly sensitive C-reactive protein (Beckman Coulter, Inc., Brea, CA, USA), erythrocyte sedimentation rate (ESR) (TEST-1; Alifax, Polverara, Italy), and leukocytes from complete blood count (CBC) (Sysmex, Kobe, Japan), and fecal inflammatory biomarkers including calprotectin (Ridascreen®; R-Biopharm, Darmstadt, Germany), lactoferrin (Abcam; Cambridge, UK), MPO (Abcam), and PMN-e (Abcam) were assessed quantitatively. Fecal leukocytes were examined using microscopy. An average number of leukocytes that was ≥1/high power field was considered positive. Fecal occult blood was examined by an immunochemical occult blood test (OC-Sensor Diana; Eiken Chemical Co., Ltd. Tokyo, Japan). A result that was ≥100 ng/mL was considered positive.

Diarrheagenic pathogen detection

Conventional stool culture using selective agars for Salmonella, Shigella, and Vibrio species was performed. Multiplex PCR for stool specimens was performed using the Seeplex® Diarrhea ACE detection kit (Seegene, Seoul, Korea) for the detection of four viruses (astrovirus, enteric adenovirus, group A rotavirus, and norovirus GI/GII), and 10 bacteria (Aeromonas spp., Campylobacter spp., C. difficile toxin B, Clostridium perfringens, E. coli O157:H7, verocytotoxin-producing E. coli (VTEC), Salmonella spp., Shigella spp., Yersinia enterocolitica, and Vibrio spp.). Fecal microscopic examination for intestinal protozoal parasites was also performed.

Statistics

Results are presented as median (range) or number (percentage). Categorical data were tested using the χ2 test or Fisher's exact test for small expected frequencies. Mann-Whitney U-test was used for continuous data. Statistical analysis was performed with SPSS version 13.0 (SPSS Inc., Chicago, IL, USA). Receiver operator characteristic (ROC) curve analysis was performed by MedCalc Statistical Software version 15.6.1 (MedCalc Software bvba, Ostend, Belgium; https://www.medcalc.org; 2015). A p-value ≤0.05 was considered statistically significant.

RESULTS

Patient demographics and clinical parameters

A total of 62 pediatric patients were included in this study. Clinical findings are summarized in Table 1. The median age of patients was 2 years (range, 1 month to 18 years). Forty-five patients (72.6%) were male. Chief complaints of all patients improved without complication at discharge. Fever, bloody diarrhea, diarrheagenic bacteria, and diarrheagenic viruses were included in clinical parameters. Fever was detected in 33 patients (53.2%) and bloody diarrhea in 19 patients (30.6%). Causative pathogens were detected using conventional cultures and multiplex PCR assays as follows: 18 bacteria were detected in 18 patients (29.0%), 43 viruses were detected in 40 patients (64.5%), and bacterial and viral coinfection was detected in 12 patients (19.4%). Enteric adenovirus (35%) was most prevalent, followed by norovirus (22%), Salmonella spp. (10%), and Campylobacter spp. (9%), group A rotavirus (4%), Aeromonas spp. (3%), astrovirus (1%), E. coli O157:H7 (1%), C. perfringens (1%), and C. difficile toxin B (1%) as shown in Fig. 1.
Table 1

Summary of clinical findings

pghn-22-369-i001
Clinical finding Values
Age (yr) 2 (1 mo–18 yr)
Sex, male 45 (72.6)
Fever, ≥38°C* 33 (53.2)
Bloody diarrhea* 19 (30.6)
Recovery without complication 62 (100)
Diarrheagenic bacterial pathogen* 18 (29.0)
Diarrheagenic viral pathogen* 40 (64.5)
Intestinal protozoa 0 (0)
Values are presented as median (range) or number (%).
*Clnical parameters in this study.
Fig. 1

Diarrheagenic pathogens detected in cultures and via multiplex polymerase chain reaction (n=62).

C. difficile: Clostridium difficile, C. perfringens: Clostridium perfringens, E. coli: Escherichia coli.
pghn-22-369-g001

Inflammatory biomarkers

The median values and ranges of inflammatory biomarkers in 62 pediatric patients are summarized in Table 2, and were as follows: 11.9 mg/L (0–178.0 mg/L) for CRP, 16 mm/hour (1–82 mm/hour) for ESR, and 10,300/µL (3,070–78,700/µL) for leukocytes. The inflammatory biomarker levels in feces were as follows: 282 µg/g (<30–1,800 µg/g) for calprotectin, 12.8 µg/mL (0–64.9 µg/mL) for lactoferrin, 4.2 ng/mL (0–14.9 ng/mL) for MPO, and 5 ng/mL (0–1,939 ng/mL) for PMN-e. Fecal leukocytes were detected in 15 patients (24.2%) and fecal occult blood was positive in 19 patients (30.6%).
Table 2

Summary of blood and fecal inflammatory biomarkers

pghn-22-369-i002
Inflammatory biomarker Values
Blood
CRP (mg/L) 11.9 (0–178.0)
ESR (mm/hr) 16 (1–82)
Leukocytes (/µL) 10,330 (3,070–78,700)
Fecal
Calprotectin (µg/g) 282 (<30–1,800)
Lactoferrin (µg/mL) 12.8 (0–64.9)
Myeloperoxidase (ng/mL) 4.2 (0–14.9)
PMN-e (ng/mL) 5 (0–1,939)
Leukocyte-positive, qualitative 15 (24.2)
Occult blood-positive, qualitative 19 (30.6)
Values are presented as median (range) or number (%).
CRP: C-reactive protein, ESR: erythrocyte sedimentation rate, PMN-e: polymorphonuclear elastase.

Correlation between clinical parameters and inflammatory biomarkers

Of the nine blood and fecal inflammatory biomarkers, only CRP was significantly correlated with fever in pediatric acute diarrhea (p<0.001) (Table 3). CRP, ESR, fecal calprotectin, fecal lactoferrin, fecal MPO, fecal leukocytes, and fecal occult blood were significantly associated with bacterial pathogens in acute diarrhea (p<0.001, p=0.04, p=0.03, p=0.003, p=0.02, p=0.03, p=0.002, respectively). However, no inflammatory markers were found to correlate with viral pathogens in acute pediatric diarrhea (all, p>0.05).
Table 3

Correlation between clinical parameters and inflammatory biomarkers

pghn-22-369-i003
Inflammatory biomarker Fever, ≥38°C Bloody diarrhea Bacterial pathogen Viral pathogen
Blood
CRP (mg/L) <0.001* 0.98 <0.001* 0.64
ESR (mm/hr) 0.05 0.19 0.04† 0.32
Leukocytes (/µL) 0.57 0.58 0.54 0.40
Fecal
Calprotectin (µg/g) 0.69 0.12 0.03† 0.61
Lactoferrin (µg/mL) 0.38 0.34 0.003‡ 0.22
MPO (ng/mL) 0.35 0.25 0.02† 0.53
PMN-e (µg/mL) 0.96 0.09 0.05 0.33
Leukocyte, positive 0.17 0.52 0.03† 1.00
Occult blood, positive 0.77 0.02† 0.002‡ 0.78
CRP: C-reactive protein, ESR: erythrocyte sedimentation rate, MPO: myeloperoxidase, PMN-e: polymorphonuclear elastase.
p-values were calculated by Mann-Whitney test or Fisher's exact test; *p<0.001, †p<0.05, ‡p<0.01.
The area under the curve (AUC), the best cut-off values, sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of the investigated parameters for bacterial infection are listed in Table 4. Among all the tested biomarkers, CRP showed the highest AUC (0.792), followed by fecal lactoferrin (0.739), fecal occult blood (0.715), fecal MPO (0.685), fecal calprotectin (0.675), ESR (0.674), and fecal leukocyte (0.643). Fecal calprotectin showed the highest sensitivity but the lowest specificity (38.6%) at the best cut-off value 74.0 µg/g (94.4%). Fecal leukocytes showed the highest specificity (84.1%) but lowest sensitivity (44.4%). Pairwise statistical comparison of ROCs among biomarkers showed no statistical significance (all, p>0.05).
Table 4

Diagnostic capability of tested biomarkers for bacterial infection in acute pediatric diarrhea (n=62)

pghn-22-369-i004
Biomarker AUC (%) Cut-off values TP (No.) FN (No.) TN (No.) FP (No.) Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%)
CRP and lactoferrin (µg/mL) 0.838 (0.723–0.920) 13.7, 22.8 13 5 42 2 72.2 (46.5–90.3) 95.5 (84.5–99.4) 86.7 (58.9–98.4) 89.4 (76.6–96.5) 88.7
CRP and fecal occult blood (µg/mL) 0.780 (0.650–0.870) 13.7, 100 10 8 44 0 55.6 (30.8–78.5) 100 (92.0–100) 100 (69.2–100) 84.6 (72.0–93.1) 87.1
CRP (mg/L) 0.792 (0.670–0.884) 13.7 15 3 30 14 83.3 (58.6–96.4) 68.2 (52.4–81.4) 51.7 (32.2–70.9) 90.9 (75.3–98.2) 72.6
Lactoferrin (µg/mL) 0.739 (0.611–0.842) 22.8 14 4 31 13 77.8 (52.4–93.6) 70.5 (54.8–83.2) 51.8 (31.6–71.6) 88.6 (72.9–96.9) 72.6
Fecal occult blood (ng/mL) 0.715 (0.586–0.822) 100 11 7 36 8 61.1 (35.7–82.7) 81.8 (67.3–91.8) 57.9 (33.1–80.1) 83.7 (69.0–93.3) 75.8
MPO (ng/mL) 0.685 (0.555–0.797) 4.14 14 4 25 19 77.8 (52.4–93.6) 56.8 (41.0–71.7) 42.4 (25.2–61.1) 86.2 (68.0–96.2) 62.9
Calprotectin (µg/g) 0.675 (0.544–0.788) 74.0 17 1 17 27 94.4 (72.7–99.9) 38.6 (24.4–54.5) 38.6 (24.1–54.8) 94.4 (72.2–99.9) 54.8
ESR (mm/hr) 0.674 (0.542–0.789) 25 11 7 32 12 61.1 (35.7–82.7) 72.7 (57.2–85.0) 47.8 (26.8–69.4) 82.1 (66.5–92.5) 71.0
Fecal leukocyte (/HPF) 0.643 (0.511–0.760) 1 8 11 37 7 44.4 (21.5–69.2) 84.1 (69.9–93.4) 53.3 (26.2–79.1) 78.7 (64.1–89.4) 72.6
Values are presented as number only, data (95% confidence interval), or percent only.
AUC: area under the curve, TP: true positive, FN: false negative, TN: true negative, FP: false positive, PPV: positive predictive value, NPV: negative predictive value, CRP: C-reactive protein, MPO: myeloperoxidase, ESR: erythrocyte sedimentation rate, HPF: high power field.
The combination of CRP and fecal lactoferrin showed the highest AUC (0.838) and accuracy (88.7%) for bacterial infection, which were higher than with individual biomarkers alone. The combination showed moderate sensitivity (72.2%) and high specificity (95.5%) (Table 4, Fig. 2). Pairwise statistical comparison of ROCs for the combination of CRP and fecal lactoferrin with ESR, lactoferrin, and calprotectin was as follows: p=0.011 for ESR, p=0.024 for lactoferrin, and p=0.006 for calprotectin, while comparison of ROCs for the combination of CRP and fecal lactoferrin with other biomarkers showed no statistical significance (all, p>0.05).
Fig. 2

Receiver operator characteristic plots of CRP, fecal lactoferrin, and the combination of CRP and fecal lactoferrin at their best cut-off values (CRP at 13.7 mg/L, lactoferrin at 22.8 μg/mL).

CRP: C-reactive protein.
pghn-22-369-g002
The combination of CRP and fecal occult blood showed the highest specificity (100%) but low sensitivity (55.6%). Pairwise statistical comparison of ROCs for the combination of CRP and fecal occult blood with other biomarkers showed no statistical significance (all, p>0.05).

DISCUSSION

In this study, CRP, fecal lactoferrin, fecal leukocytes, and fecal occult blood were correlated with bacterial etiology in acute pediatric diarrhea. Among the biomarkers tested in this study, only CRP was correlated with both fever and bacterial etiology. Fecal occult blood was useful in determining bacterial etiology in pediatric acute diarrhea, but it was not a sensitive marker, which was in line with previous studies [515].
CRP at a cut-off value of 13.7 mg/L showed moderate diagnostic sensitivity (83.3%) and specificity (68.2%) with a 29% prevalence of bacterial diarrhea in this study. These results were similar to a prior study reported by Berger et al. [16] in which a CRP cut-off value of 20 mg/L showed a sensitivity of 83% and a specificity of 67% at a 24% prevalence of serious bacterial infections [17]. The findings are also in line with previous reports indicating that CRP has moderate sensitivity and specificity to detect bacterial infection in children with fever and can discriminate inflammatory from non-inflammatory diarrhea in young adults without underlying gastrointestinal diseases [1718].
Various fecal neutrophil-derived inflammatory biomarkers have been considered for noninvasive initial diagnosis and monitoring of inflammatory bowel disease in children [8910111920]. These biomarkers play a potential role in the assessment and diagnosis of various gastrointestinal conditions [20]. Although lactoferrin was less sensitive in determining the bacterial etiology of acute pediatric diarrhea than CRP in this study, it was better than the other fecal neutrophil-derived inflammatory biomarkers including calprotectin, MPO, and PMN-e. Most importantly, the combination of CRP and lactoferrin showed a higher diagnostic capability for bacterial etiology in acute pediatric diarrhea compared with their use alone. Therefore, lactoferrin may be used in conjunction with CRP in the differential diagnosis of bacterial infection in acute pediatric diarrhea without underlying gastrointestinal diseases.
There are several limitations in our study. First, the number of enrolled patients with bacterial diarrhea was relatively small because of the viral prevalence in childhood. Second, we failed to exclude all bacterial and viral pathogens in cases of acute diarrhea. Third, the positive PCR results may not represent the actual infectious status.
In summary, CRP is a useful marker for both fever and bacterial etiology in acute pediatric diarrhea. The combination of CRP and fecal lactoferrin has better diagnostic capability in ascertaining bacterial etiology than their use alone in acute pediatric diarrhea without underlying gastrointestinal diseases.

Notes

Conflict of Interest The authors have no financial conflicts of interest.

References

1. Lanata CF, Fischer-Walker CL, Olascoaga AC, Torres CX, Aryee MJ, Black RE, et al. Global causes of diarrheal disease mortality in children <5 years of age: a systematic review. PLoS One. 2013; 8:e72788.
2. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 385:117–171.
3. Thielman NM, Guerrant RL. Clinical practice. Acute infectious diarrhea. N Engl J Med. 2004; 350:38–47.
4. Shastri YM, Bergis D, Povse N, Schäfer V, Shastri S, Weindel M, et al. Prospective multicenter study evaluating fecal calprotectin in adult acute bacterial diarrhea. Am J Med. 2008; 121:1099–1106.
crossref
5. Lee HM, Lee S, Lee BI, Jekarl DW, Song JY, Choi HJ, et al. Clinical significance of fecal lactoferrin and multiplex polymerase chain reaction in patients with acute diarrhea. Gut Liver. 2015; 9:636–640.
crossref
6. Nudelman R, Kagan BM. C-reactive protein in pediatrics. Adv Pediatr. 1983; 30:517–547.
7. Jaye DL, Waites KB. Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J. 1997; 16:735–746.
crossref
8. Chen CC, Huang JL, Chang CJ, Kong MS. Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children. J Pediatr Gastroenterol Nutr. 2012; 55:541–547.
crossref
9. Sutherland AD, Gearry RB, Frizelle FA. Review of fecal biomarkers in inflammatory bowel disease. Dis Colon Rectum. 2008; 51:1283–1291.
crossref
10. Peterson CG, Eklund E, Taha Y, Raab Y, Carlson M. A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease. Am J Gastroenterol. 2002; 97:1755–1762.
crossref
11. Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol. 2008; 103:162–169.
crossref
12. Chen CC, Chang CJ, Lin TY, Lai MW, Chao HC, Kong MS. Usefulness of fecal lactoferrin in predicting and monitoring the clinical severity of infectious diarrhea. World J Gastroenterol. 2011; 17:4218–4224.
crossref
13. Sýkora J, Siala K, Huml M, Varvařovská J, Schwarz J, Pomahačová R. Evaluation of faecal calprotectin as a valuable non-invasive marker in distinguishing gut pathogens in young children with acute gastroenteritis. Acta Paediatr. 2010; 99:1389–1395.
crossref
14. Lee S, Park YJ, Lee HK, Kim SY, Kim JY, Lee SY, et al. Detection of 13 enteric bacteria and 5 viruses causing acute infectious diarrhea using multiplex PCR from direct stool specimens. Ann Clin Microbiol. 2013; 16:33–38.
crossref
15. Bardhan PK, Beltinger J, Beltinger RW, Hossain A, Mahalanabis D, Gyr K. Screening of patients with acute infectious diarrhoea: evaluation of clinical features, faecal microscopy, and faecal occult blood testing. Scand J Gastroenterol. 2000; 35:54–60.
crossref
16. Berger RM, Berger MY, van Steensel-Moll HA, Dzoljic-Danilovic G, Derksen-Lubsen G. A predictive model to estimate the risk of serious bacterial infections in febrile infants. Eur J Pediatr. 1996; 155:468–473.
crossref
17. Sanders S, Barnett A, Correa-Velez I, Coulthard M, Doust J. Systematic review of the diagnostic accuracy of C-reactive protein to detect bacterial infection in nonhospitalized infants and children with fever. J Pediatr. 2008; 153:570–574.
crossref
18. Kim DH, Kang SH, Jeong WS, Moon HS, Lee ES, Kim SH, et al. Serum C-reactive protein (CRP) levels in young adults can be used to discriminate between inflammatory and non-inflammatory diarrhea. Dig Dis Sci. 2013; 58:504–508.
crossref
19. Joishy M, Davies I, Ahmed M, Wassel J, Davies K, Sayers A, et al. Fecal calprotectin and lactoferrin as noninvasive markers of pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2009; 48:48–54.
crossref
20. Pang T, Leach ST, Katz T, Day AS, Ooi CY. Fecal biomarkers of intestinal health and disease in children. Front Pediatr. 2014; 2:6.
crossref
TOOLS
Similar articles